🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multicenter, randomized, double-blind, active-controlled study aims to...
Status
Active Not Recruiting
Location
Dermatology Hospital of Shandong First Medical University (Shandong Provincial Hospitial of Dermatology)
Start Date
2025-05-27
Trial ID
NCT06945107
Treatments Being Tested
The purpose of this study was to demonstrate efficacy of autoinjector admin...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-10-17
Trial ID
NCT01636687
Treatments Being Tested
The purpose of this study is to demonstrate the efficacy and safety of secu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-10-03
Trial ID
NCT02721966
Treatments Being Tested
The purpose of this study was to demonstrate superiority of secukinumab at ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-01-31
Trial ID
NCT03713619
Treatments Being Tested
The purpose of this extension study is to evaluate maintenance of Hidradeni...
Status
Completed
Location
Northwest Arkansas Center
Start Date
2020-03-18
Trial ID
NCT04179175
Treatments Being Tested
This is a multi-center phase 2b study in subjects with moderate to severe c...
Status
Completed
Location
Investigative Site
Start Date
2018-07-31
Trial ID
NCT03384745
Treatments Being Tested
To demonstrate that the efficacy of secukinumab 300 mg at Week 16 was super...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-06-27
Trial ID
NCT02798211
Treatments Being Tested
This is a single-arm, open-label study, which will examine the effect of se...
Status
Completed
Location
UCSF Psoriasis and Skin Treatment Center
Start Date
2016-10
Trial ID
NCT02592018
Treatments Being Tested
The reason for this study is to see how effective and safe mirikizumab is c...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2018-06-26
Trial ID
NCT03535194
Treatments Being Tested